BDBM309360 (2R,3aS,4R,9bS)-12-(cyclopropylmethyl)- 3a-hydroxy-8-methoxy-1,2,3,3a,4,5- hexahydro-4,9b-(epiminoethano)cyclo- penta[a]naphthalene-2-carboxamide::US9656962, Compound 11

SMILES COc1ccc2C[C@H]3N(CC4CC4)CC[C@@]4(C[C@H](C[C@@]34O)C(N)=O)c2c1

InChI Key InChIKey=IOOHMAGDMPHDJV-UHFFFAOYSA-N

Data  2 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 309360   

TargetKappa-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM309360(US9656962, Compound 11 | (2R,3aS,4R,9bS)-12-(cyclo...)
Affinity DataKi:  182nMAssay Description:Radioligand binding assays (screening and dose-displacement) use 0.1 nM [3H]-nociceptin (Perkin Elmer, Shelton, Conn.; 87.7 Ci/mmole) with 12 μg...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2019
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Purdue Pharma

US Patent
LigandPNGBDBM309360(US9656962, Compound 11 | (2R,3aS,4R,9bS)-12-(cyclo...)
Affinity DataKi:  2.98E+3nMAssay Description:δ-Opioid Receptor Binding Assay Procedures: δ-Opioid Receptor Binding Assay Procedures were conducted as follows. Radioligand dose-displace...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/8/2019
Entry Details
US Patent